Asset Entities, Inc. Class B ASST 深 沪
已收盘 12-19 16:00:00 美东时间
0.8942
+0.063
+7.63%
华盛通- 最 高1.19
- 今 开0.865
- 成交量 4566.89万股
- 最 低 0.7805
- 昨 收 0.8308
- 总市值 0
- 52周最高 13.42
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.3865
- 委 比 67.73%
- 总股本 --
- 历史最高 13.42
- 量 比 0.55
- 振 幅 49.29%
- 历史最低 0.21
- 每 手 1
- 风险率 2.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vivek Ramaswamy's Bitcoin Treasury Company Is Facing Turbulence: Momentum Score Plummets
Former Republican Presidential Candidate and current Ohio state gubernatorial hopeful Vivek Ramaswamy’s Bitcoin (CRYPTO: BTC) treasury company i
12-16 18:01
Asset Entities大涨46.3%，公司将与Strive Enterprises合并
美股周三早盘，Asset Entities（ASST）股价大涨46.3%，此前该公司股东批准其与Strive Enterprises合并，以组建一家公开上市的比特币储备公司，潜在总收益预计超过15亿美元。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
09-10 23:02
Asset Entities(ASST)盘前大涨超107% 与Strive合并 成立比特币财库公司
金吾财讯 | Asset Entities(ASST)盘前大涨超107%，截至发稿，报13.08美元。 消息面上，Asset Entities股东批准与Vivek Ramaswamy旗下Strive合并，合并后公司更名为Strive, Inc.，继续纳斯达克交易，Matt Cole任CEO。合并旨在打造专注比特币的数字资产财库公司，并计划完成7.5亿美元私募融资。
09-10 20:11
Strive Asset Management and Asset Entities (Nasdaq: ASST) Announce $750M Private Investment to Fund First Wave of Bitcoin Accumulation
Asset Entities and Strive Asset Management announce a $750 million PIPE with potential $1.5 billion total proceeds, aiming to establish Strive as a leading Bitcoin treasury company. CEO Matt Cole will discuss their Bitcoin strategies at the Bitcoin for Corporations Symposium.
05-27 13:00
US Stocks Mixed; Trade Gap Widens In July
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 0.1% on Wednesday. The Dow traded up 0.10% to 40,978.50 while the NASDAQ fell 0.23% to 17,096.94. The S&P 500 also fell, dropping, 0.01% to 5,528.99. Check This Out: Top 3 Consumer Stocks That Could Blast Off This Quarter...
2024-09-04 22:06
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM). Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in tod...
2024-09-04 01:41
